Development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung

PneumoNP is a collaborative research program funded under the Seventh Framework Programme, with a €5.7 million grant. Starting in 2014, it is aiming at the development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung, with focus on Klebsiella pneumoniae caused infections.

 

Latest news from PneumoNP

Our workshop 2016: “Novel approaches to fight bacteria”

The raise of antimicrobial resistance urges the development of novel approaches to bring antibiotics into bacteria. This workshop provides an interdisciplinary overview of ...
Read More

How to pack antibiotics in nanocarriers

Polymeric and lipidic nanocarriers may be appropriate to wrap and carry antibiotics into lungs infected by pneumonia. PneumoNP researchers work on ...
Read More